Effects of Rosuvastatin on aortic stenosis progression - ASTRONOMER

Study identifier:DC-452-0003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Effect of Cholesterol Lowering on the Progression of Aortic Stenosis in Patients with Mild to Moderate Aortic Stenosis (ASTRONOMER)Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin and The Sub-Study Protocol.

Medical condition

Aortic Stenosis

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin, Placebo

Sex

All

Actual Enrollment

378

Study type

Interventional

Age

18 Years - 82 Years

Date

Study Start Date: 01 Nov 2002
Primary Completion Date: 01 Sept 2008
Study Completion Date: 01 Sept 2008

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

University of Ottawa Heart Institute

Inclusion and exclusion criteria